NEW YORK, April 19, 2018 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced the appointment of Nick Pizzie, CPA, MBA, as Chief Financial Officer (CFO), effective May 16, 2018.
Name: John Golubieski
Continent: North America
Company: Axsome Therapeutics, Inc.
Announcement Date: April 18, 2018, 10:00pm
Resignation Date: April 18, 2018, 10:00pm